Francesca Zanelli

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Marcello Tiseo, Luca Boni, Francesca Ambrosio et al. · Journal of Clinical Oncology · 2017 · 184 citations

Medicine, Oncology, Pharmacotherapy +12

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 147 citations · Full text

Medicine, Oncology, Pharmacology +13

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Carmine Pinto, Paolo Andrea Zucali, Maria Pagano et al. · The Lancet Oncology · 2021 · 103 citations

Medicine, Oncology, Pharmacology +12

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Marcello Tiseo, Paola Bordi, Beatrice Bortesi et al. · British Journal of Cancer · 2013 · 72 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power

Enrico Franceschi, Alicia Tosoni, Santino Minichillo et al. · World Neurosurgery · 2018 · 58 citations · Full text

Medicine, Genetics, Oncology +17